Atlas Trials

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Clinical trial NCT01580020 · COMPLETED

Trial details

NCT number
NCT01580020
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Retinal Vein Occlusion
Start date
2012-05-01
Primary completion
2014-10-01
Enrollment
175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.